Steven Z Chao1, Brandy R Matthews2, Jennifer S Yokoyama3, Ngan Betty Lai3, Hilary Ong3, Marian Tse3, Runfen Frances Yuan3, Amy Lin3, Joel Kramer3, Kristine Yaffe4, John Kornak5, Bruce L Miller3, Howard J Rosen6. 1. Department of Neurology, VA Palo Alto Health Care System, Palo Alto, CA; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA. 2. Department of Neurology, Indiana University School of Medicine, Indiana Alzheimer Disease Center, Indianapolis, IN. 3. Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA. 4. Departments of Psychiatry, Neurology, and Epidemiology and Biostatistics, University of California, San Francisco, and Memory Disorders Clinic, San Francisco VA Medical Center, San Francisco, CA. 5. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 6. Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA. Electronic address: hrosen@memory.ucsf.edu.
Abstract
OBJECTIVES: To compare the prevalence of depressive symptoms and frequency of antidepressant use between a group of elderly Chinese-American subjects with and without cognitive impairment and a group of matched white subjects. A secondary aim was to examine the clinical and demographic predictors of depressive symptoms across these groups. METHODS: The study was conducted at an academic neurology subspecialty clinic. This was a case-control study with 140 Chinese-American subjects and 140 demographically and cognitively matched white subjects. In each group, there were 48 cognitively normal and 92 cognitively impaired participants (49 with mild cognitive impairment, 43 with Alzheimer disease). The proportion of individuals with significant depressive symptoms, as indicated by a Geriatric Depression Scale score ≥6 of 15, and frequency of antidepressant use were compared across groups by using χ(2) analysis. Factors predicting depressive symptoms, including racial and diagnostic group, age, gender, Mini-Mental State Examination score, level of functional impairment, education level, and medical comorbidities, were assessed by using linear regression analysis. RESULTS: Significant depressive symptoms were more common in cognitively impaired Chinese-American (35%) than cognitively impaired white (15%; χ(2)[1] = 9.4; p = 0.004) subjects. Chinese-American subjects with cognitive impairment were less likely to be receiving treatment for depression (12%) than white subjects with cognitive impairment (37%; χ(2)[1] = 15.6; p = 0.002). Racial and diagnostic group, age, level of functional impairment, Mini-Mental State Examination score, and education level were all statistically significant independent predictors of Geriatric Depression Scale score. CONCLUSIONS: Elderly Chinese-American subjects with cognitive impairment are at increased risk for unrecognized and untreated depressive symptoms compared with elderly white subjects with cognitive impairment. Education level may contribute to this risk or it may be a surrogate marker for other factors contributing to depressive symptoms in this group.
OBJECTIVES: To compare the prevalence of depressive symptoms and frequency of antidepressant use between a group of elderly Chinese-American subjects with and without cognitive impairment and a group of matched white subjects. A secondary aim was to examine the clinical and demographic predictors of depressive symptoms across these groups. METHODS: The study was conducted at an academic neurology subspecialty clinic. This was a case-control study with 140 Chinese-American subjects and 140 demographically and cognitively matched white subjects. In each group, there were 48 cognitively normal and 92 cognitively impaired participants (49 with mild cognitive impairment, 43 with Alzheimer disease). The proportion of individuals with significant depressive symptoms, as indicated by a Geriatric Depression Scale score ≥6 of 15, and frequency of antidepressant use were compared across groups by using χ(2) analysis. Factors predicting depressive symptoms, including racial and diagnostic group, age, gender, Mini-Mental State Examination score, level of functional impairment, education level, and medical comorbidities, were assessed by using linear regression analysis. RESULTS: Significant depressive symptoms were more common in cognitively impaired Chinese-American (35%) than cognitively impaired white (15%; χ(2)[1] = 9.4; p = 0.004) subjects. Chinese-American subjects with cognitive impairment were less likely to be receiving treatment for depression (12%) than white subjects with cognitive impairment (37%; χ(2)[1] = 15.6; p = 0.002). Racial and diagnostic group, age, level of functional impairment, Mini-Mental State Examination score, and education level were all statistically significant independent predictors of Geriatric Depression Scale score. CONCLUSIONS: Elderly Chinese-American subjects with cognitive impairment are at increased risk for unrecognized and untreated depressive symptoms compared with elderly white subjects with cognitive impairment. Education level may contribute to this risk or it may be a surrogate marker for other factors contributing to depressive symptoms in this group.
Authors: C G Lyketsos; C Steele; L Baker; E Galik; S Kopunek; M Steinberg; A Warren Journal: J Neuropsychiatry Clin Neurosci Date: 1997 Impact factor: 2.198
Authors: Albert Yeung; Raymond Chan; David Mischoulon; Shamsah Sonawalla; Eileen Wong; Andrew A Nierenberg; Maurizio Fava Journal: Gen Hosp Psychiatry Date: 2004 Jan-Feb Impact factor: 3.238
Authors: Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella Journal: Nurs Outlook Date: 2017-06-16 Impact factor: 3.250
Authors: Mark B Snowden; David C Atkins; Lesley E Steinman; Janice F Bell; Lucinda L Bryant; Catherine Copeland; Annette L Fitzpatrick Journal: Am J Geriatr Psychiatry Date: 2014-09-21 Impact factor: 4.105
Authors: Luke W Bonham; Daniel W Sirkis; Jia Fan; Renan E Aparicio; Marian Tse; Eliana Marisa Ramos; Qing Wang; Giovanni Coppola; Howard J Rosen; Bruce L Miller; Jennifer S Yokoyama Journal: Neurocase Date: 2017-02 Impact factor: 0.881
Authors: Jia Fan; Marian Tse; Jessie S Carr; Bruce L Miller; Joel H Kramer; Howard J Rosen; Luke W Bonham; Jennifer S Yokoyama Journal: Alzheimer Dis Assoc Disord Date: 2019 Jul-Sep Impact factor: 2.703